{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T21:02:29Z","timestamp":1777669349041,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["T32CA009001"],"award-info":[{"award-number":["T32CA009001"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MGH Executive Committee on Research","award":["Physician Scientist Development Award"],"award-info":[{"award-number":["Physician Scientist Development Award"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10552-026-02151-2","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T13:46:35Z","timestamp":1775223995000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparing endocrine therapy adherence across EHR and claims data by race and ethnicity, language, and insurance"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5001-7298","authenticated-orcid":false,"given":"Michelle O.","family":"Sodipo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia K.","family":"Morgans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorelei A.","family":"Mucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audra Hite","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beza","family":"Tadess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastien","family":"Haneuse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2671-0313","authenticated-orcid":false,"given":"Erica T.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"issue":"5","key":"2151_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3322\/caac.21731","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller KD et al (2022) Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin 72(5):409\u2013436. https:\/\/doi.org\/10.3322\/caac.21731","journal-title":"CA Cancer J Clin"},{"issue":"25","key":"2151_CR2","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1056\/NEJMp2200244","volume":"386","author":"I Jatoi","year":"2022","unstructured":"Jatoi I, Sung H, Jemal A (2022) The emergence of the racial disparity in U.S. breast-cancer mortality. N Engl J Med 386(25):2349\u20132352. https:\/\/doi.org\/10.1056\/NEJMp2200244","journal-title":"N Engl J Med"},{"issue":"3","key":"2151_CR3","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10549-020-05984-w","volume":"185","author":"F Zhao","year":"2021","unstructured":"Zhao F et al (2021) Racial disparities in survival outcomes among breast cancer patients by molecular subtypes. Breast Cancer Res Treat 185(3):841\u2013849. https:\/\/doi.org\/10.1007\/s10549-020-05984-w","journal-title":"Breast Cancer Res Treat"},{"issue":"32","key":"2151_CR4","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1200\/JCO.23.02311","volume":"42","author":"JM Torres","year":"2024","unstructured":"Torres JM, Sodipo MO, Hopkins MF, Chandler PD, Warner ET (2024) Racial differences in breast cancer survival between black and white women according to tumor subtype: a systematic review and meta-analysis. J Clin Oncol 42(32):3867\u20133879. https:\/\/doi.org\/10.1200\/JCO.23.02311","journal-title":"J Clin Oncol"},{"issue":"20","key":"2151_CR5","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1200\/JCO.2014.57.1349","volume":"33","author":"ET Warner","year":"2015","unstructured":"Warner ET et al (2015) Racial and ethnic differences in breast cancer survival: mediating effect of tumor characteristics and sociodemographic and treatment factors. J Clin Oncol 33(20):2254\u20132261. https:\/\/doi.org\/10.1200\/JCO.2014.57.1349","journal-title":"J Clin Oncol"},{"issue":"11","key":"2151_CR6","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/onco.13964","volume":"26","author":"KE Reeder-Hayes","year":"2021","unstructured":"Reeder-Hayes KE, Troester MA, Wheeler SB (2021) Adherence to endocrine therapy and racial outcome disparities in breast cancer. Oncologist 26(11):910\u2013915. https:\/\/doi.org\/10.1002\/onco.13964","journal-title":"Oncologist"},{"issue":"2","key":"2151_CR7","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s10549-010-1132-4","volume":"126","author":"DL Hershman","year":"2011","unstructured":"Hershman DL et al (2011) Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat 126(2):529\u2013537. https:\/\/doi.org\/10.1007\/s10549-010-1132-4","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"2151_CR8","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1158\/1940-6207.CAPR-13-0389","volume":"7","author":"RT Chlebowski","year":"2014","unstructured":"Chlebowski RT, Kim J, Haque R (2014) Adherence to endocrine therapy in breast cancer adjuvant and prevention settings. Cancer Prev Res 7(4):378\u2013387. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-13-0389","journal-title":"Cancer Prev Res"},{"issue":"9","key":"2151_CR9","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1200\/JCO.2014.58.3062","volume":"33","author":"DL Hershman","year":"2015","unstructured":"Hershman DL, Tsui J, Wright JD, Coromilas EJ, Tsai WY, Neugut AI (2015) Household net worth, racial disparities, and hormonal therapy adherence among women with early-stage breast cancer. J Clin Oncol 33(9):1053\u20131059. https:\/\/doi.org\/10.1200\/JCO.2014.58.3062","journal-title":"J Clin Oncol"},{"issue":"1","key":"2151_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11096-013-9865-x","volume":"36","author":"A Lehmann","year":"2014","unstructured":"Lehmann A et al (2014) Assessing medication adherence: options to consider. Int J Clin Pharm 36(1):55\u201369. https:\/\/doi.org\/10.1007\/s11096-013-9865-x","journal-title":"Int J Clin Pharm"},{"issue":"8","key":"2151_CR11","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/bjc.2012.389","volume":"107","author":"R Font","year":"2012","unstructured":"Font R et al (2012) Prescription refill, patient self-report and physician report in assessing adherence to oral endocrine therapy in early breast cancer patients: a retrospective cohort study in Catalonia, Spain. Br J Cancer 107(8):1249\u20131256. https:\/\/doi.org\/10.1038\/bjc.2012.389","journal-title":"Br J Cancer"},{"issue":"1","key":"2151_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-474","volume":"12","author":"AS Oberguggenberger","year":"2012","unstructured":"Oberguggenberger AS et al (2012) Adherence evaluation of endocrine treatment in breast cancer: methodological aspects. BMC Cancer 12(1):474. https:\/\/doi.org\/10.1186\/1471-2407-12-474","journal-title":"BMC Cancer"},{"key":"2151_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2020.106007","volume":"93","author":"TA Battaglia","year":"2020","unstructured":"Battaglia TA et al (2020) Translating research into practice: protocol for a community-engaged, stepped wedge randomized trial to reduce disparities in breast cancer treatment through a regional patient navigation collaborative. Contemp Clin Trials 93:106007. https:\/\/doi.org\/10.1016\/j.cct.2020.106007","journal-title":"Contemp Clin Trials"},{"issue":"7","key":"2151_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.116","volume":"108","author":"B Makubate","year":"2013","unstructured":"Makubate B, Donnan PT, Dewar JA, Thompson AM, McCowan C (2013) Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality. Br J Cancer 108(7):Art. no. 7. https:\/\/doi.org\/10.1038\/bjc.2013.116","journal-title":"Br J Cancer"},{"key":"2151_CR15","unstructured":"R Core Team, R: A Language and Environment for Statistical Computing. (2023). R Foundation for Statistical Computing, Vienna, Austria. [Online]. Available: https:\/\/www.R-project.org\/"},{"issue":"4","key":"2151_CR16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.18553\/jmcp.2022.28.4.473","volume":"28","author":"CA Kitchen","year":"2022","unstructured":"Kitchen CA, Chang H-Y, Bishop MA, Shermock KM, Kharrazi H, Weiner JP (2022) Comparing and validating medication complexity from insurance claims against electronic health records. J Manag Care Spec Pharm 28(4):473\u2013484. https:\/\/doi.org\/10.18553\/jmcp.2022.28.4.473","journal-title":"J Manag Care Spec Pharm"},{"issue":"4","key":"2151_CR17","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.3821","volume":"3","author":"M Sharma","year":"2020","unstructured":"Sharma M, Johnson ML, Zhao H, Giordano SH, Holmes HM (2020) Concordance between electronic health record data and Medicare Part D claims data for oral anticancer drug use. JAMA Netw Open 3(4):e203821. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.3821","journal-title":"JAMA Netw Open"},{"issue":"S3","key":"2151_CR18","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.2105\/AJPH.2014.302490","volume":"105","author":"MC Roberts","year":"2015","unstructured":"Roberts MC, Wheeler SB, Reeder-Hayes K (2015) Racial\/ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: a systematic review. Am J Public Health 105(S3):e4\u2013e15. https:\/\/doi.org\/10.2105\/AJPH.2014.302490","journal-title":"Am J Public Health"},{"issue":"4","key":"2151_CR19","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/acr.25269","volume":"76","author":"T Beukelman","year":"2024","unstructured":"Beukelman T et al (2024) Using electronic health records and linked claims data to assess new medication use and primary nonadherence in rheumatology patients. Arthritis Care Res (Hoboken) 76(4):550\u2013558. https:\/\/doi.org\/10.1002\/acr.25269","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2151_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ahj.2017.09.019","volume":"197","author":"JM Franklin","year":"2018","unstructured":"Franklin JM et al (2018) The relative benefits of claims and electronic health record data for predicting medication adherence trajectory. Am Heart J 197:153\u2013162. https:\/\/doi.org\/10.1016\/j.ahj.2017.09.019","journal-title":"Am Heart J"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-026-02151-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-026-02151-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-026-02151-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:52:50Z","timestamp":1777449170000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-026-02151-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2151"],"URL":"https:\/\/doi.org\/10.1007\/s10552-026-02151-2","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Study protocol and procedures were approved by the Mass General Brigham Institutional Review Board (Protocol #: 2019P002378).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This study was conducted under a waiver of informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"No individually identifiable data in any form (including any individual details, images, or videos) are presented in this manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"73"}}